Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
Euro primary continues pumping out trades with JDE Peet's and Covivio lining up -
Swiss pharma company navigates a difficult market to pay a negative to zero new issue premium
-
Strong name recognition helps Swiss pharma company achieve size at a tight price
-
Novartis spin off looks to build on jubilant reception it had last month in Swissies
-
French biotech company is raising capital for R&D and debt refinancing
-
The Finnish biopharmaceutical company tapped shareholders for capital on Thursday night
